| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
78,043 |
70,178 |
$4.78M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
53,038 |
46,178 |
$4.40M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
38,985 |
35,636 |
$1.70M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
22,225 |
19,511 |
$1.28M |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
50,620 |
42,924 |
$1.10M |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
109,759 |
50,196 |
$1.02M |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
29,570 |
28,152 |
$756K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
54,052 |
48,631 |
$602K |
| 99051 |
|
15,001 |
14,068 |
$197K |
| 87807 |
|
16,945 |
15,238 |
$159K |
| 87428 |
|
2,518 |
1,948 |
$81K |
| 99215 |
Prolong outpt/office vis |
496 |
435 |
$36K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,062 |
2,631 |
$23K |
| 99205 |
Prolong outpt/office vis |
156 |
148 |
$17K |
| 71046 |
Radiologic examination, chest; 2 views |
545 |
529 |
$17K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,215 |
1,132 |
$16K |
| 99000 |
|
6,825 |
6,403 |
$14K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
258 |
223 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
558 |
414 |
$5K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
174 |
129 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
202 |
152 |
$2K |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
444 |
431 |
$2K |
| 81003 |
|
724 |
623 |
$1K |
| 81002 |
|
365 |
362 |
$930.35 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
115 |
112 |
$609.69 |
| 0071A |
|
35 |
35 |
$511.59 |
| 0072A |
|
17 |
14 |
$463.56 |
| 73610 |
|
16 |
13 |
$462.20 |
| 73630 |
|
12 |
12 |
$411.24 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
25 |
25 |
$403.80 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
14 |
14 |
$263.13 |
| 86308 |
|
32 |
26 |
$150.00 |
| S8431 |
Compression bandage, roll |
12 |
12 |
$116.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
78 |
71 |
$29.06 |
| 94761 |
|
627 |
597 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
13 |
13 |
$0.00 |